The initial public offering market has taken a step back for now, as geopolitical strife and unstable markets have created uncertainty, historically a momentum killer for upcoming IPOs. That wasn' ...
After several years of IPO drought in the biotech industry, the public market is picking up again. Will the trend keep going ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results